Transepithelial Photorefractive Keratectomy in Moderate to High Astigmatism With a Non-wavefront–Guided Aberration-Neutral Ablation Profile

光折变性角膜切除术 散光 屈光度 烧蚀 眼科 医学 眼睛畸变 球差 折射误差 角膜地形图 视力 光学 验光服务 镜头(地质) 物理 内科学
作者
Diego de Ortueta,Dennis von Rüden,Shwetabh Verma,Thomas Magnago,Samuel Arba-Mosquera
出处
期刊:Journal of Refractive Surgery [Slack Incorporated (United States)]
卷期号:34 (7): 466-474 被引量:21
标识
DOI:10.3928/1081597x-20180402-04
摘要

To evaluate the outcomes of transepithelial photorefractive keratectomy (PRK) in moderate to high astigmatism with a non-wavefront-guided aberration-neutral ablation profile using SmartPulse allocation.In this retrospective study, myopic patients with a preoperative cylinder of 2.00 diopters (D) or greater were analyzed at 3 months of follow-up. Transepithelial PRK treatments were performed in each patient with the Amaris 1050RS laser (SCHWIND eye-tech-solutions, Kleinostheim, Germany) creating aspheric ablation profiles by applying a SmartPulse allocation. Standard examinations and wavefront analyses were included for low and high ocular residual astigmatism subgroups.Fifty-eight eyes (44 patients) were included in the cohort. The eyes were divided into separate ocular residual astigmatism subgroups: 17 eyes presented with less than 0.50 D (low ocular residual astigmatism) and 24 eyes with greater than 0.75 D (high ocular residual astigmatism). The mean refractive cylinder in the entire cohort was 2.84 ± 0.86 D preoperatively and 0.40 ± 0.39 D postoperatively, with 81% of the eyes within 0.75 D of the target astigmatism. At 3 months of follow-up, significant improvement (P < .05) was seen in terms of sphere, cylinder, spherical equivalent, and uncorrected (UDVA) and corrected (CDVA) distance visual acuity. CDVA improved in 40% of eyes and 3% of eyes lost one line of CDVA. No clinically relevant changes were seen in higher order aberrations. The refractive changes showed an excellent match with the keratometric changes. The difference between the low and high ocular residual astigmatism subgroups was not significant except for the change of Snellen lines of CDVA (P < .05).Transepithelial PRK using a non-wavefront-guided aberration-neutral ablation profile performed by applying SmartPulse allocation yielded excellent visual outcomes. The preoperative astigmatism was reduced to subclinical values. Both subgroups were effective in terms of UDVA, CDVA, spherical and astigmatic correction, and preserving higher order aberrations. However, the low ocular residual astigmatism subgroup was slightly more prone to gain lines of CDVA. [J Refract Surg. 2018;34(7):466-474.].

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ChangShengtzu完成签到 ,获得积分10
1秒前
monoklatt完成签到,获得积分10
1秒前
张鱼小丸子完成签到,获得积分10
1秒前
1秒前
dxt完成签到,获得积分10
1秒前
ty完成签到,获得积分10
2秒前
高高朋友完成签到,获得积分10
2秒前
3秒前
超级的友儿完成签到,获得积分10
3秒前
纯真老鼠完成签到,获得积分10
3秒前
hellen123完成签到,获得积分10
3秒前
专注垣完成签到,获得积分10
4秒前
超的爱123完成签到,获得积分10
4秒前
4秒前
lulu完成签到 ,获得积分10
4秒前
duoduo完成签到 ,获得积分10
4秒前
咪咪完成签到,获得积分10
5秒前
咿呀完成签到,获得积分10
5秒前
5秒前
瘦瘦的烤鸡完成签到,获得积分10
5秒前
共享精神应助燕燕于飞采纳,获得10
5秒前
cdercder应助燕燕于飞采纳,获得10
5秒前
zlk112zr完成签到,获得积分10
5秒前
yanziwu94完成签到,获得积分10
5秒前
7秒前
菠菜应助辛勤如柏采纳,获得10
7秒前
无花果应助郗文慧采纳,获得10
7秒前
7秒前
Priscilla完成签到,获得积分10
7秒前
求知的周完成签到,获得积分10
8秒前
Went完成签到,获得积分10
8秒前
小婷完成签到,获得积分10
8秒前
搞怪的思卉完成签到,获得积分10
9秒前
鸣蜩阿六完成签到,获得积分10
9秒前
Jenny完成签到,获得积分10
9秒前
ZHD发布了新的文献求助10
9秒前
迷路的翠容完成签到,获得积分10
10秒前
七月夏栀完成签到,获得积分10
10秒前
159完成签到 ,获得积分10
10秒前
优雅含灵完成签到 ,获得积分10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951786
求助须知:如何正确求助?哪些是违规求助? 8636020
关于积分的说明 18311955
捐赠科研通 6394399
什么是DOI,文献DOI怎么找? 3082215
关于科研通互助平台的介绍 2127533
邀请新用户注册赠送积分活动 2059101